Dear Members, please see the latest MedTech Europe ECHA CLP update. If Any of these are used in your products, please let me know at regulatory@bivda.org.uk
With this email, we would like to inform you about the latest chemical developments at ECHA and kindly ask you to indicate if any of the following impact your company by 18 March.
CLP
- Proposal to harmonise classification and labelling – link here:
- Cyflufenamid (EC -, CAS 180409-60-3)
- Intentions to harmonise classification and labelling – link here:
-
- bixafen (ISO); N-(3′,4′-dichloro-5-fluorobiphenyl-2-yl)-3-(difluoromethyl)-1-methyl-1H-pyrazole-4-carboxamide (EC -, CAS 581809-46-3)
- Reaction mass of α,α-4-trimethyl-(1S)-3-cyclohexene-1-methanol and α,α-4-trimethyl-(1R)-3-cyclohexene-1-methanol and 1-methyl-4-(1-methylethylidene)-cyclohexanol (EC -, CAS -)
- flumetylsulforim (ISO); 5-fluoro-4-imino-3-methyl-1-[(4-methylphenyl)sulfonyl]-3,4-dihydropyrimidin-2(1H)-one (EC -, CAS 1616664-98-2)
- pyrimethanil (ISO); N-(4,6-dimethylpyrimidin-2-yl)aniline (EC 414-220-3, CAS 53112-28-0)
- 4-Dimethylaminoazobenzene; Solvent Yellow 2 (EC 200-455-7, CAS 60-11-7)
- Withdrawal to harmonise classification and labelling – link here:
- Propylidynetrimethanol; 2-ethyl-2-(hydroxymethyl)propane-1,3-diol (EC 201-074-9, CAS 77-99-6)
